138 related articles for article (PubMed ID: 25100012)
1. HMGA1 is a new target of miR-195 involving isoprenaline-induced cardiomyocyte hypertrophy.
You XY; Huang JH; Liu B; Liu SJ; Zhong Y; Liu SM
Biochemistry (Mosc); 2014 Jun; 79(6):538-44. PubMed ID: 25100012
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.
Wang YS; Zhou J; Hong K; Cheng XS; Li YG
Cell Physiol Biochem; 2015; 35(4):1546-56. PubMed ID: 25792377
[TBL] [Abstract][Full Text] [Related]
3. MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells.
Wang CQ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3771-3778. PubMed ID: 31115003
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
5. Expression of miR‑26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells.
Sekimoto N; Suzuki A; Suzuki Y; Sugano S
Mol Med Rep; 2017 Feb; 15(2):534-542. PubMed ID: 28000891
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X
Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961
[TBL] [Abstract][Full Text] [Related]
7. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
8. Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation.
Kaddar T; Rouault JP; Chien WW; Chebel A; Gadoux M; Salles G; Ffrench M; Magaud JP
Biol Cell; 2009 Sep; 101(9):511-24. PubMed ID: 19250063
[TBL] [Abstract][Full Text] [Related]
9. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling.
Yuan Y; Wang J; Chen Q; Wu Q; Deng W; Zhou H; Shen D
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1421-1427. PubMed ID: 30794866
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy.
Li Q; Song XW; Zou J; Wang GK; Kremneva E; Li XQ; Zhu N; Sun T; Lappalainen P; Yuan WJ; Qin YW; Jing Q
J Cell Sci; 2010 Jul; 123(Pt 14):2444-52. PubMed ID: 20571053
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of miR-146b-5p alleviates isoprenaline-induced cardiac hypertrophy via regulating DFCP1.
Liu S; Su L; Li J; Zhang Y; Hu X; Wang P; Liu P; Ye J
Mol Cell Endocrinol; 2024 Aug; 589():112252. PubMed ID: 38649132
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group AT-hook 1 promotes cardiac dysfunction in diabetic cardiomyopathy via autophagy inhibition.
Wu QQ; Liu C; Cai Z; Xie Q; Hu T; Duan M; Wu H; Yuan Y; Tang Q
Cell Death Dis; 2020 Mar; 11(3):160. PubMed ID: 32123163
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG1 exerts a protective role in cardiomyocytes hypertrophy via targeting miR-15a-5p/HMGA1 axis.
Yan SM; Li H; Shu Q; Wu WJ; Luo XM; Lu L
Cell Biol Int; 2020 Apr; 44(4):1009-1019. PubMed ID: 31889385
[TBL] [Abstract][Full Text] [Related]
15. High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells.
Zhang Y; Ma T; Yang S; Xia M; Xu J; An H; Yang Y; Li S
Mol Cell Biochem; 2011 Nov; 357(1-2):363-71. PubMed ID: 21656127
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.
Huang ZP; Chen J; Seok HY; Zhang Z; Kataoka M; Hu X; Wang DZ
Circ Res; 2013 Apr; 112(9):1234-43. PubMed ID: 23524588
[TBL] [Abstract][Full Text] [Related]
17. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
[TBL] [Abstract][Full Text] [Related]
18. miR-374 promotes myocardial hypertrophy by negatively regulating vascular endothelial growth factor receptor-1 signaling.
Lee JS; Song DW; Park JH; Kim JO; Cho C; Kim DH
BMB Rep; 2017 Apr; 50(4):208-213. PubMed ID: 27802840
[TBL] [Abstract][Full Text] [Related]
19. miR-30a downregulation aggravates pressure overload-induced cardiomyocyte hypertrophy.
Yin X; Peng C; Ning W; Li C; Ren Z; Zhang J; Gao H; Zhao K
Mol Cell Biochem; 2013 Jul; 379(1-2):1-6. PubMed ID: 23660952
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.
Song XW; Li Q; Lin L; Wang XC; Li DF; Wang GK; Ren AJ; Wang YR; Qin YW; Yuan WJ; Jing Q
J Cell Physiol; 2010 Nov; 225(2):437-43. PubMed ID: 20458739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
